Glp-1 Licensing Market Research Report

Global Market Size, Share & Trends Analysis Report, 2026-2035

Segmentation Analysis By Molecule Type: By Application: By Licensing Type: By End Use: By Region and Industry Forecast

Download Sample Request Customization Talk to Analyst
Market Size 2026
13.5 Billion
Market Size 2027
15.5 Billion
Forecast CAGR (2026–2035)
14.5%
Forecast Market Value (2035)
45.6 Billion
Leading Regional Market
North America
Fastest-Growing Regional Market:
Asia Pacific

1. Market Segmentation

Glp-1 Licensing Market Segmentation

By Molecule Type:

  • Semaglutide
  • Tirzepatide
  • Liraglutide
  • Exenatide
  • Dulaglutide

By Application:

  • Type 2 Diabetes
  • Obesity & Weight Management
  • Cardiovascular Disease
  • Nash & Metabolic Disorders

By Licensing Type:

  • Out-licensing
  • In-licensing
  • Co-development Agreements
  • Royalty-based Licensing

By End Use:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Manufacturing Organizations

By Geography:

  • North America: United States, Canada, Mexico
  • Europe: United Kingdom, Germany, France, Spain, Italy, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Rest of Latin America
  • Middle East & Africa: Saudi Arabia, South Africa, Rest of MEA